Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Cell biology of CML cells Gordon MY; Dazzi F; Marley SB; Lewis JL; Nguyen D; Grand FH; Davidson RJ; Goldman JMLeukemia 1999[Apr]; 13 Suppl 1 (�): S65-71At the cellular level, expansion of haemopoiesis in chronic myeloid leukaemia (CML) must involve some imbalance in cell production along the myeloid maturation pathway. The relevant kinetic parameters are cell loss by apoptosis and differentiation and cell gain by proliferation (self-renewal). In spite of the predominance of the BCR-ABL-positive leukaemic cells, some BCR-ABL-negative, presumably normal, progenitor cells remain for long periods in chronic phase CML. Thus, understanding the kinetics of CML and normal progenitor cells may lead to therapeutic strategies capable of reducing malignant cell growth and reactivating normal haemopoiesis.|Antineoplastic Agents/pharmacology[MESH]|Apoptosis[MESH]|Blast Crisis/pathology[MESH]|Cell Differentiation[MESH]|Cell Division[MESH]|Disease Progression[MESH]|Drug Design[MESH]|Fusion Proteins, bcr-abl/physiology[MESH]|Hematopoiesis[MESH]|Hematopoietic Stem Cells/cytology[MESH]|Humans[MESH]|Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/genetics/*pathology[MESH]|Neoplastic Stem Cells/*cytology[MESH]|Tumor Cells, Cultured[MESH] |